80 results
424B3
QTTB
Q32 Bio Inc.
29 Apr 24
Prospectus supplement
5:10pm
pipeline in the long term. We have multiple product candidates across a variety of autoimmune and inflammatory diseases with clinical readouts for our … ; and
the FDA or other regulatory authorities may require us to submit additional data such as long-term toxicology studies or impose other
8-K
EX-99.5
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
and development - long term
Other
Total other noncurrent assets
F-19
6. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current … and CMOs are generally cancellable, with notice, at the Company’s option.
Operating lease
In 2021 the Company entered into a long-term operating lease
8-K
EX-10.11
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
”) of Q32 Bio Inc. (the “Company”) is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high
8-K
EX-99.4
gnrrnn e52p
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K
EX-10.4
ue29 u2yb
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K
EX-99.3
3deqytajpchs76a
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K
EX-99.2
jhurj
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K
EX-99.1
o5ndnam8d z1
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
424B3
7jykzwlmtliiok8m4mc
13 Mar 24
Prospectus supplement
1:36pm
425
dlc vnissa75ei
21 Feb 24
Business combination disclosure
4:04pm
424B3
v9quz o1e3e
14 Feb 24
Prospectus supplement
4:10pm
S-4/A
ncydrz5q
29 Jan 24
Registration of securities issued in business combination transactions (amended)
12:00am
8-K
EX-99.1
y40caqvrahnmw wgy2d
26 Jan 24
Regulation FD Disclosure
4:13pm
425
rwmf aptafe7vd7z
26 Jan 24
Business combination disclosure
12:00am
S-4
EX-2.1
uk3ezvge
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm